Hospital-specific GPS aims to improve efficiency, patient flow

Navigating so many hallways, deciphering signs and going up and down flights of stairs—a hospital can be a tricky place to navigate, especially for the unfamiliar.

Connexient, a New York-based firm specializing in location-based services, has designed the MediNav Navigator Edition 2.0 specifically for healthcare settings.

Essentially a GPS for hospitals, the MediNav is a map that can be pulled up at any time through the mobile app. The app provides turn-by-turn directions and shows patient flow. By tracking patient flow and facility management, the app is capable of reducing costs and increasing efficiency to hospitals. If everyone knew exactly where they needed to go and avoid the traffic jams of overpopulated areas, there’s no doubt that hospitals will be able to deliver care more efficiently while improving patients' on-site experiences.

Froedtert & the Medical College of Wisconsin (MCW) health network in MIlwaukee is the latest to offer this mobile app to its patients.

"Like many large healthcare organizations, Froedtert & the MCW leaders want to enhance the experience of patients and simplify wayfinding for patients, visitors and even staff. MediNav brings the same benefits of outdoor navigation enjoyed by millions of users to the indoor world,” said Mark Green, Connexient CEO and co-founder. “In addition, improved wayfinding can also help to capture lost revenues by reducing late and missed appointments. Just as importantly."

Along with navigation, the app includes a section for parking, provides indoor and outdoor navigation tips and can integrate into other apps on a patient’s smartphone.

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.